NCT06415838

Brief Summary

The goal of this randomized clinical trial is to investigate if a brief psychological treatment called Behavioral Activation (BA) works to prevent and treat depression in older adults in a municipal context in Sweden. It will also learn about the patients' and therapists' experiences of the BA-treatment. The main questions it aims to answer are if the BA-treatment has an effect on the short and long term on:

  • Depressive symptoms
  • Anxiety symptoms
  • Self-rated activation
  • Functional ability
  • Loneliness
  • Self efficacy
  • Mental wellbeing
  • Quality of life
  • Need for community care services All participants will continue their care as usual (CAU), and half of the participants will be randomized to receive a five-session BA-treatment spread over two months as an add-on to CAU. All participants will answer a questionnaire in the beginning of the study, after two months, and after 3-, 6- and 12 months.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P50-P75 for not_applicable depression

Timeline
3mo left

Started Jun 2024

Typical duration for not_applicable depression

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Jun 2024Aug 2026

First Submitted

Initial submission to the registry

May 7, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 16, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

June 27, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

December 16, 2024

Status Verified

December 1, 2024

Enrollment Period

1.4 years

First QC Date

May 7, 2024

Last Update Submit

December 11, 2024

Conditions

Keywords

Behavioral activationBehavior therapyPsychological treatmentOlder adultsGeriatric

Outcome Measures

Primary Outcomes (1)

  • Montgomery-Åsberg Depression Rating Scale, MADRS-S

    Depressive symptoms will be measured with the Montgomery-Åsberg Depression Rating Self-rating Scale (MADRS-S). The MADRS-S is a nine-item questionnaire designed to measure depression severity during the past two weeks. The total score ranges from 0-54, with higher scores indicating higher depression severity.

    Baseline; post-intervention or equivalent for control group 9 weeks after baseline; 3-, 6- and 12 months post-intervention or equivalent for control group

Secondary Outcomes (9)

  • Geriatric Depression Scale 15, GDS-15

    Baseline; post-intervention or equivalent for control group 9 weeks after baseline; 3-, 6- and 12 months post-intervention or equivalent for control group

  • Geriatric Anxiety Scale 10, GAS-10

    Baseline; post-intervention or equivalent for control group 9 weeks after baseline; 3-, 6- and 12 months post-intervention or equivalent for control group

  • WHO disability assessment schedule 12-item, WHODAS-12

    Baseline; post-intervention or equivalent for control group 9 weeks after baseline; 3-, 6- and 12 months post-intervention or equivalent for control group

  • Behavioral activation for depression scale - short form, BADS-SF

    Baseline; post-intervention or equivalent for control group 9 weeks after baseline; 3-, 6- and 12 months post-intervention or equivalent for control group

  • UCLA Loneliness Scale version 3, UCLA-LS 3

    Baseline; post-intervention or equivalent for control group 9 weeks after baseline; 3-, 6- and 12 months post-intervention or equivalent for control group

  • +4 more secondary outcomes

Study Arms (2)

Brief Behavioral Activation plus Care as Usual

EXPERIMENTAL

Five-session Brief Behavioral Activation intervention. Sessions 1 - 4 are completed once a week, and session 5 is a booster-session completed four weeks after session 4.

Behavioral: Brief Behavioral ActivationOther: Care as Usual

Care as Usual

ACTIVE COMPARATOR

Care as usual as provided by primary care and/or municipal care.

Other: Care as Usual

Interventions

A five-session brief behavioral activation treatment delivered face-to-face in the participants' home. Session outline: Session 1: Psychoeducation about depression; treatment rationale for Behavioral Activation (BA); rationale and instructions for activity log Session 2: Discussion of life goals and values; planning of activities aligned with life goals and values for coming week Session 3: Troubleshooting any problems carrying out activities; planning activities aligned with life goals and values for coming week. Session 4: Troubleshooting any problems carrying out activities; planning activities aligned with life goals and values for the coming week; instructing the participant to independently continue to plan activities for the coming month. Session 5: Troubleshooting any problems carrying out activities; reviewing treatment; stressing the importance of continuing to engage in activities aligned with life goals and values; creating a maintenance plan.

Brief Behavioral Activation plus Care as Usual

Care as Usual provided by primary care and/or municipal care.

Brief Behavioral Activation plus Care as UsualCare as Usual

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • years or older
  • points or above on the Geriatric Depression Scale 15, GDS-15
  • Fluent in written and spoken Swedish
  • Consents to participate in the trial

You may not qualify if:

  • Not able to use the patient materials due to visual impairment
  • Not able to communicate with therapist due to hearing impairment
  • Diagnosis of major neurocognitive disorder
  • Below 25 points on the Mini Mental State Examination, MMSE
  • Elevated suicide risk
  • Current substance- or alcohol use disorder
  • Previous or current psychotic disorder
  • Previous or current bipolar disorder
  • Ongoing psychological treatment/pscyhotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eskilstuna kommun

Eskilstuna, Sörmland, Sweden

RECRUITING

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Johnny Pellas, PhD

    Research and Development Sormland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marina Arkkukangas, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 7, 2024

First Posted

May 16, 2024

Study Start

June 27, 2024

Primary Completion

December 1, 2025

Study Completion (Estimated)

August 1, 2026

Last Updated

December 16, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Study protocol and statistical analysis plan to be shared/published before data collection has ended.

Locations